display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/adv melanoma (mML)
mML - NA - all populationmML - L1 - all populationmML - L1 - BRAF wildmML - L2 - all population
nivolumab alone CheckMate 238 IMMUNED ... CheckMate 067 ... CheckMate 066 CheckMate 037

Study type: